Suchergebnisse - "Immunosuppressants"

PubPharm (131.555)

71

Organ involvement in newly diagnosed sarcoidosis patients in the Netherlands : The first large European multicentre prospective study

enthalten in: Respiratory medicine | 2024

von Van Woensel, J. | Koopman, B. | Schiefer, M. | +8

72

Exploration of the underlying mechanism of Astragaloside III in attenuating immunosuppression via network pharmacology and vitro/vivo pharmacological validation

enthalten in: Journal of ethnopharmacology | 2024

von He, Y. | Amer, H. | Xu, Z. | +5

73

Biofunctional Inorganic Layered Double Hydroxide Nanohybrid Enhances Immunotherapeutic Effect on Atopic Dermatitis Treatment

enthalten in: Small (Weinheim an der Bergstrasse, Germany) | 2024

von Byun, M. | Seo, H. | Lee, J. | +16

74

Feasibility of discontinuing immunosuppression in children with idiopathic nephrotic syndrome

enthalten in: Pediatric nephrology (Berlin, Germany) | 2024

von Sobue, Y. | Nishi, K. | Kamei, K. | +9

75

Nervogenic Acid Derivatives and Phenanthrenes from Liparis nervosa and Their Antimicrobial and Immunosuppressive Activities

enthalten in: Chemistry & biodiversity | 2024

von Jiang, H. | Liu, Y. | Ren, B. | +3

76

Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway

enthalten in: BMC biology | 2024

von Zhang, Y. | Lei, Y. | Ou, Q. | +7

77

Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway

enthalten in: BMC biology | 2024

von Zhang, Y. | Lei, Y. | Ou, Q. | +7

78

Intra-arterial methylprednisolone for pediatric gastrointestinal post-transplant lymphoproliferative disorder

enthalten in: Pediatric hematology and oncology | 2024

von Jung, H. | Dhatt, R. | Rassekh, S. | +1

79

Risk factors for severe hearing loss in Susac syndrome : A national cohort study

enthalten in: European journal of neurology | 2024

von Peyre, M. | Mageau, A. | Henry Feugeas, M. | +34

80

Graphene oxide films as a novel tool for the modulation of myeloid-derived suppressor cell activity in the context of multiple sclerosis

enthalten in: Nanoscale | 2024

von Camacho-Toledano, C. | Machín-Díaz, I. | Lebrón-Galán, R. | +4